Sutro Biopharma (STRO) Profit After Tax Growth (1y) (2018 - 2025)
Sutro Biopharma (STRO) Profit After Tax Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | 0.26% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | -107.76% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | 101.22% |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 6,968.66% |
| 10 | Sutro Biopharma | 205.22 Mn | 63.79 Mn | - | 35.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.45% |
| Sep 30, 2025 | -16.54% |
| Jun 30, 2025 | 76.05% |
| Mar 31, 2025 | -30.50% |
| Dec 31, 2024 | -333.20% |
| Sep 30, 2024 | 1.01% |
| Jun 30, 2024 | -24.64% |
| Mar 31, 2024 | -16.31% |
| Dec 31, 2023 | 189.80% |
| Sep 30, 2023 | -152.89% |
| Jun 30, 2023 | -48.10% |
| Mar 31, 2023 | -27.97% |
| Dec 31, 2022 | 9.26% |
| Sep 30, 2022 | 36.94% |
| Jun 30, 2022 | -322.82% |
| Mar 31, 2022 | -28.83% |
| Dec 31, 2021 | 35.97% |
| Sep 30, 2021 | -280.30% |
| Jun 30, 2021 | -120.59% |
| Mar 31, 2021 | -54.93% |